These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 39011577)
1. Effect of different exit-site care dressings on preventing peritoneal dialysis related infection from nontropical area: a systematic review and network meta-analysis. Feng C; Liu Y; Jin W; Lu M; Su CY Ren Fail; 2024 Dec; 46(2):2376331. PubMed ID: 39011577 [TBL] [Abstract][Full Text] [Related]
2. Exit-Site Dressing and Infection in Peritoneal Dialysis: A Randomized Controlled Pilot Trial. Mushahar L; Mei LW; Yusuf WS; Sivathasan S; Kamaruddin N; Idzham NJ Perit Dial Int; 2016; 36(2):135-9. PubMed ID: 26374836 [TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
4. Dressings and securement devices for central venous catheters (CVC). Ullman AJ; Cooke ML; Mitchell M; Lin F; New K; Long DA; Mihala G; Rickard CM Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD010367. PubMed ID: 26358142 [TBL] [Abstract][Full Text] [Related]
5. Comparison between types of dressing following catheter insertion and early exit-site infection in peritoneal dialysis. Figueiredo AE; de Mattos C; Saraiva C; Olandoski M; Barretti P; Pecoits Filho R; de Moraes TP; J Clin Nurs; 2017 Nov; 26(21-22):3658-3663. PubMed ID: 28122398 [TBL] [Abstract][Full Text] [Related]
6. The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial. Zhang L; Badve SV; Pascoe EM; Beller E; Cass A; Clark C; de Zoysa J; Isbel NM; McTaggart S; Morrish AT; Playford EG; Scaria A; Snelling P; Vergara LA; Hawley CM; Johnson DW; Perit Dial Int; 2015 Dec; 35(7):712-21. PubMed ID: 26224790 [TBL] [Abstract][Full Text] [Related]
7. ["Naked" exit-site for peritoneal dialysis catheters]. Previti A; Savi U; Lentini P; Bandera A G Ital Nefrol; 2022 Feb; 39(1):. PubMed ID: 35191628 [TBL] [Abstract][Full Text] [Related]
8. Catheter type, placement and insertion techniques for preventing catheter-related infections in chronic peritoneal dialysis patients. Htay H; Johnson DW; Craig JC; Schena FP; Strippoli GF; Tong A; Cho Y Cochrane Database Syst Rev; 2019 May; 5(5):CD004680. PubMed ID: 31149735 [TBL] [Abstract][Full Text] [Related]
9. Gauze and tape and transparent polyurethane dressings for central venous catheters. Webster J; Gillies D; O'Riordan E; Sherriff KL; Rickard CM Cochrane Database Syst Rev; 2011 Nov; (11):CD003827. PubMed ID: 22071809 [TBL] [Abstract][Full Text] [Related]
11. Epidemiology, management, and prevention of exit site infections in peritoneal dialysis patients. Sachar M; Shah A Ther Apher Dial; 2022 Apr; 26(2):275-287. PubMed ID: 34435734 [TBL] [Abstract][Full Text] [Related]
12. Comparative Effectiveness of Local Application of Chlorhexidine Gluconate, Mupirocin Ointment, and Normal Saline for the Prevention of Peritoneal Dialysis-related Infections (COSMO-PD Trial): a multicenter randomized, double-blind, controlled protocol. Nochaiwong S; Ruengorn C; Noppakun K; Panyathong S; Dandecha P; Sood MM; Saenjum C; Awiphan R; Sirilun S; Mongkhon P; Chongruksut W; Thavorn K; Trials; 2019 Dec; 20(1):754. PubMed ID: 31856900 [TBL] [Abstract][Full Text] [Related]
13. Comparison of Topical Chlorhexidine and Mupirocin for the Prevention of Exit-Site Infection in Incident Peritoneal Dialysis Patients. Htay H; Johnson DW; Wu SY; Oei EL; Foo MWY; Choo JCJ Perit Dial Int; 2017; 37(3):266-272. PubMed ID: 28183858 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness of moist dressings in wound healing after surgical suturing: A Bayesian network meta-analysis of randomised controlled trials. Sun W; Chen M; Duan D; Liu W; Cui W; Li L Int Wound J; 2023 Jan; 20(1):69-78. PubMed ID: 35546485 [TBL] [Abstract][Full Text] [Related]
15. [Fungal peritoneal dialysis catheter-related exit-site infection combined with tunnel infection: A case report]. Qiao J; Lu LX; He YT; Men CC; Chu XX; Wu B; Zhao HP; Wang M Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 55(4):748-754. PubMed ID: 37534662 [TBL] [Abstract][Full Text] [Related]
16. Catheter type, placement and insertion techniques for preventing peritonitis in peritoneal dialysis patients. Strippoli GF; Tong A; Johnson D; Schena FP; Craig JC Cochrane Database Syst Rev; 2004 Oct; (4):CD004680. PubMed ID: 15495125 [TBL] [Abstract][Full Text] [Related]
17. Prevention of peritoneal dialysis catheter infections in Saudi peritoneal dialysis patients: the emergence of high-level mupirocin resistance. Al-Hwiesh AK; Abdul-Rahman IS; Al-Muhanna FA; Al-Sulaiman MH; Al-Jondebi MS; Divino-Filho JC Int J Artif Organs; 2013 Jul; 36(7):473-83. PubMed ID: 23897229 [TBL] [Abstract][Full Text] [Related]
18. Chlorhexidine-impregnated sponge dressing for prevention of catheter exit-site infection in peritoneal dialysis patients: a pilot study. Htay H; Choo JCJ; Johnson DW; Pascoe EM; Jayaballa M; Oei EL; Ng LC; Wu SY; Foo MWY Int Urol Nephrol; 2021 Apr; 53(4):803-812. PubMed ID: 33025409 [TBL] [Abstract][Full Text] [Related]
19. Effect of local mupirocin application on exit-site infection and peritonitis in an Indian peritoneal dialysis population. Mahajan S; Tiwari SC; Kalra V; Bhowmik DM; Agarwal SK; Dash SC; Kumar P Perit Dial Int; 2005; 25(5):473-7. PubMed ID: 16178481 [TBL] [Abstract][Full Text] [Related]
20. Devices and dressings to secure peripheral venous catheters to prevent complications. Marsh N; Webster J; Mihala G; Rickard CM Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011070. PubMed ID: 26068958 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]